Identification of ASF1B as a prognostic marker for liver cancer by meta-analysis and its immune value revealed by a comprehensive pan-cancer analysis of 33 human cancers
Gastroenterology Review · 2023 · 18 (3) · 249-265
DOI: 10.5114/pg.2023.124423 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gastroenterology Review, 2023. Verfasst von Yiyang Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, Anhui Medical University, College of Clinical College of Shenzhen Hospital of Peking University, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatopancreatobiliary Surgery, Anhui Medical University, College of Clinical College of Shenzhen Hospital of Peking University, China.
- Department of Hepatopancreatobiliary Surgery, Peking University Shenzhen Hospital, Shenzhen, China.
Zitieren
APA
Chen, Y., Zhou, W., Gong, Y., & Ou, X. (2023). Identification of ASF1B as a prognostic marker for liver cancer by meta-analysis and its immune value revealed by a comprehensive pan-cancer analysis of 33 human cancers. Gastroenterology Review, 18(3), 249-265. https://doi.org/10.5114/pg.2023.124423
Vancouver
Chen Y, Zhou W, Gong Y, Ou X. Identification of ASF1B as a prognostic marker for liver cancer by meta-analysis and its immune value revealed by a comprehensive pan-cancer analysis of 33 human cancers. Gastroenterology Review. 2023;18(3):249-265. doi:10.5114/pg.2023.124423
BibTeX
@article{Chen2023,
author = {Chen, Yiyang and Zhou, Wanbang and Gong, Yiju and Ou, Xi},
title = {Identification of ASF1B as a prognostic marker for liver cancer by meta-analysis and its immune value revealed by a comprehensive pan-cancer analysis of 33 human cancers},
journal = {Gastroenterology Review},
year = {2023},
volume = {18},
number = {3},
pages = {249--265},
doi = {10.5114/pg.2023.124423}
}
EUVIMED